1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. ZYDUS LIFESCIENCES LTD.

Zydus Lifesciences Ltd.

NSE: ZYDUSLIFE | BSE: 532321

Mid-range Performer
Download real time

885.60 -2.65 (-0.30%)

33.13% Fall from 52W High

814.5K NSE+BSE Volume

NSE 02 May, 2025 3:31 PM (IST)

Watchlist

Portfolio

Alert

Share
19S
2W
9O
4T
22,247.4

Operating Revenue TTM

High in industry
4,675

Net profit TTM

High in industry
21

Net Profit Margin TTM %

16.9

Operating Revenue growth TTM %

Above industry Median
57.2

Net Profit TTM Growth %

Above industry Median
US FDA Approval
Zydus Life gets US FDA approval for Niacin tablets with annual US sales of $5.5 million See details

Zydus Lifesciences Ltd. quarterly, annual results, revenue, profit, P&L, Balance Sheet, Cash Flow, Annual Reports, Margins - 15 Years history